Johns Hopkins Study: COVID-19 Vaccination in Patients with Chronic Conditions

COVID-19 Antibody Testing of Patients with Chronic Conditions is being led by a team of researchers at Johns Hopkins Medicine. The purpose of the study is to determine the safety of the COVID-19 vaccine as well as COVID-19 antibody levels in patients who receive the vaccine with the following chronic conditions: HIV, an autoimmune condition, cirrhosis, or on home dialysis.